SEC Comment Letter for Opus Genetics, Inc. (IRD) (CIK 0001228627) (IRD) — Mar 23, 2011

Opus Genetics, Inc. (IRD) (CIK 0001228627)
Date: March 23, 2011 · CIK: 0001228627 · Accession: 0000000000-11-017879

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-34079

Date

March 23, 2011

Author

Jim B. Rosenberg

Form

UPLOAD

Company

Opus Genetics, Inc. (IRD) (CIK 0001228627)

Letter

March 23, 2011 Mr. Tae Heum Jeong Chief Financial Officer Rexahn Pharmaceuticals, Inc. 15245 Shady Grove Road, Suite 455 Rockville, MD 20850

Re: Rexahn Pharmaceuticals, Inc. Form 10-K for the year ended December 31, 2009 Filed March 31, 2010 Schedule 14A filed April 26, 2010 File No. 001-34079

Dear Mr. Jeong:

We have completed our review of your fili ngs and do not have any further comments at this time. Sincerely, Jim B. Rosenberg Senior Assistant Chief Accountant

Show Raw Text

March 23, 2011
  Mr. Tae Heum Jeong Chief Financial Officer Rexahn Pharmaceuticals, Inc. 15245 Shady Grove Road, Suite 455 Rockville, MD  20850

Re: Rexahn Pharmaceuticals, Inc.
Form 10-K for the year ended December 31, 2009
Filed March 31, 2010
Schedule 14A filed April 26, 2010
File No. 001-34079

Dear Mr. Jeong:

We have completed our review of your fili ngs and do not have any further comments at
this time.
 Sincerely,    Jim B. Rosenberg Senior Assistant Chief Accountant

SecProbe.io